Editing Endocrine disruptor (section)

== Economic effects ==
Human exposure may cause some health effects, such as lower [[Intelligence quotient|IQ]], adult [[obesity]], female [[Reproductive system disease|reproductive disorders]], and male reproductive disorders.<ref name=":3">{{Cite journal |last=Kassotis |first=Christopher D. |last2=Vandenberg |first2=Laura N. |last3=Demeneix |first3=Barbara A. |last4=Porta |first4=Miquel |last5=Slama |first5=Remy |last6=Trasande |first6=Leonardo |date=August 2020 |title=Endocrine-disrupting chemicals: economic, regulatory, and policy implications |url=https://pmc.ncbi.nlm.nih.gov/articles/PMC7437819/ |journal=The Lancet. Diabetes & Endocrinology |volume=8 |issue=8 |pages=719–730 |doi=10.1016/S2213-8587(20)30128-5 |issn=2213-8595 |pmc=7437819 |pmid=32707119}}</ref> These effects may lead to lost productivity, disability, or premature death in some people. One source estimated that, within the [[European Union]], this economic effect might have about twice the [[Economic impact analysis|economic impact]] as the effects caused by mercury and [[Lead poisoning|lead contamination]].<ref name="pmid25742516">{{cite journal |author5-link=Philippe Grandjean (professor) |vauthors=Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, DiGangi J, Bellanger M, Hauser R, Legler J, Skakkebaek NE, Heindel JJ |date=2015 |title=Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union |journal=The Journal of Clinical Endocrinology and Metabolism |volume=100 |issue=4 |pages=1245–55 |doi=10.1210/jc.2014-4324 |pmc=4399291 |pmid=25742516}}</ref>

Within the last 5 years, the socio-economic burden of EDC-associated health effects was recorded at an estimated annual cost of €163 in the EU and $340 billion in the USA, which can even be viewed as an underestimate due to how many health outcomes take place due to EDC exposure<ref name=":3" />